# THIOTEPA
> **ANDA211755** · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2023-09-05
## Drug
- **FDA Application Number:** ANDA211755
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** THIOTEPA
- **Generic name:** THIOTEPA
- **Active ingredients:** THIOTEPA
- **Dosage form:** POWDER
- **Route:** INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
- **Marketing status:** Prescription
- **Sponsor:** HIKMA
- **Manufacturer:** Hikma Pharmaceuticals USA Inc.
- **First approval:** 2023-09-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211755)
---
*AI Analytics · CC0 1.0*